VYNE Therapeutics Inc.
Ticker: 1566044
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 | Q2 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.09+28.6% | 0.07-65.0% | 0.20+66.7% | 0.12-40.0% | 0.20+100.0% | 0.10-9.1% | 0.11-21.4% | 0.14 |
| Total Income | 0.09+28.6% | 0.07-65.0% | 0.20+66.7% | 0.12-40.0% | 0.20+100.0% | 0.10-9.1% | 0.11-21.4% | 0.14 |
| EXPENSES | ||||||||
| Expenditure | 3.90-48.8% | 7.61-19.0% | 9.40-28.8% | 13.21+24.7% | 10.59+41.6% | 7.48+17.8% | 6.35-39.2% | 10.45 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PROFIT | ||||||||
| PBT | -3.59+37.6% | -5.75+33.1% | -8.60+29.3% | -12.16-29.4% | -9.40-50.6% | -6.24-2.8% | -6.07+39.5% | -10.04 |
| Net Profit | -3.59+37.7% | -5.76+33.1% | -8.61+29.2% | -12.16-29.2% | -9.41-50.6% | -6.25+5.0% | -6.58+34.6% | -10.06 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.08+38.5% | -0.13+35.0% | -0.20+31.0% | -0.29-31.8% | -0.22-46.7% | -0.15+92.5% | -2.01+35.0% | -3.09 |
Corporate Events
Board MeetingVYNE
202616Jul
Board Meeting
Stockholders to vote on the approval of the merger with Yarr…
SEC Filing ↗